| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.1M | +496.0% |
| Cost of Revenue | $11.4M | — |
| R&D Expense | $138.4M | +6.1% |
| SG&A Expense | $101.1M | +116.2% |
| Operating Income | -$241.4M | -34.3% |
| Interest Expense | $9.3M | -79.4% |
| Pre-tax Income | -$219.1M | -5.1% |
| Income Tax | $1.5M | +7935.9% |
| Net Income | -$220.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $227.4M | -5.1% |
| Accounts Receivable | $15K | -86.2% |
| Inventory | $4.1M | — |
| Current Assets | $660.9M | +140.1% |
| Total Assets | $782.7M | +108.5% |
| Current Liabilities | $60.7M | +35.8% |
| Total Liabilities | $355.4M | +34.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$206.3M | -41.7% |
| Capital Expenditures | $22.1M | +100.9% |
| Investing Cash Flow | -$394.6M | -3491.4% |
| Financing Cash Flow | $589.6M | — |
| Free Cash Flow | -$228.3M | -45.8% |
| -5.9% |
| EPS (Basic) | -$0.86 | +28.3% |
| EPS (Diluted) | -$0.86 | +28.3% |
| Stockholders' Equity |
| $427.3M |
| +283.3% |